Trials / Completed
CompletedNCT06017024
New Microprocessor-Controlled Prosthetic Knee Evaluation
Evaluation of a New Microprocessor-Controlled Prosthetic Knee : A Prospective, Multicentered, Randomized Cross-over Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Proteor Group · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The target of this clinical investigation is to compare the achievement of personal functional goals using a new MPK and current MPK. Subjects will also run functional tests and questionnaires to compare performances and feedback with each prosthetic knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | microprocessor-controlled knee (MPK) assessment | The subject will wear the microprocessor-controlled knee prosthesis for 4 weeks, and then reply questionnaires and achieve functional tests |
Timeline
- Start date
- 2023-06-07
- Primary completion
- 2024-12-11
- Completion
- 2024-12-11
- First posted
- 2023-08-30
- Last updated
- 2024-12-13
Locations
5 sites across 1 country: France
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06017024. Inclusion in this directory is not an endorsement.